1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Mark A Hull, PhD FRCP: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EPA for Metastasis Trial 2 Icosapent Ethyl, Placebo - Liver Metastasis, Colon Cancer | Phase 3 | Active not recruiting | Mark A Hull, PhD FRCP | 418 | 2018-05-02 | 2025-04-18 |
eicosapentaenoic acid ethyl ester (1)
United Kingdom (1)
Mark Hull (1)